ArticleNeuroImage. Clinical2018
[
Open access · goldAbstract read
In one paragraph
Article in NeuroImage. Clinical, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease.Frontiers in neurology · 2021Pooled it
- Amphetamine-induced dopamine release and impulsivity in Parkinson's disease.Brain : a journal of neurology · 2022Trial
- Targeting GPCR Signaling in Parkinson's Disease: From Molecular Pathology to Exercise-Based Therapeutics.Molecular neurobiology · 2026Review
- Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives.ACS chemical neuroscience · 2026Review
- Behavioral Effects of Stimulated Dopamine Release and D2-like Receptor Displacement in Parkinson's Patients with Impulse-Control Disorder.International journal of molecular sciences · 2025Article
- [Biomolecules · 2025Article
- Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin-Sensitive Magnetic Resonance Imaging andMovement disorders : official journal of the Movement Disorder Society · 2025Article
- PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.American journal of nuclear medicine and molecular imaging · 2024Review
- Accentuated Paralimbic and Reduced Mesolimbic DThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023Article
- The Role of a Dopamine-Dependent Limbic-Motor Network in Sensory Motor Processing in Parkinson Disease.Journal of cognitive neuroscience · 2023Article
- The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.Frontiers in cellular neuroscience · 2023Article
- Imaging the Limbic System in Parkinson's Disease-A Review of Limbic Pathology and Clinical Symptoms.Brain sciences · 2022Review
- Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.Life (Basel, Switzerland) · 2022Review
- Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients.NPJ Parkinson's disease · 2022Article
- DThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021Article
- Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers.Toxicological sciences : an official journal of the Society of Toxicology · 2021Article
- Allosteric Interactions between Adenosine AInternational journal of molecular sciences · 2021Review
- Self-reported rates of impulsivity in Parkinson's Disease.Annals of clinical and translational neurology · 2020Article
- Drug Choices and Advancements for Managing Depression in Parkinson's Disease.Current neuropharmacology · 2020Review
- Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.Cortex; a journal devoted to the study of the nervous system and behavior · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Adam J StarkNeurology, Vanderbilt University Medical Center, Nashville, TN, United States.
Christopher T SmithPsychology, Vanderbilt University, Nashville, TN, United States.
Kalen J PetersenNeurology, Vanderbilt University Medical Center, Nashville, TN, United States.
Paula TrujilloNeurology, Vanderbilt University Medical Center, Nashville, TN, United States.
Nelleke C van WouweNeurology, Vanderbilt University Medical Center, Nashville, TN, United States.
Manus J DonahueNeurology, Vanderbilt University Medical Center, Nashville, TN, United States; Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, United States; Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Robert M KesslerRadiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ariel Y DeutchPsychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States; Pharmacology, Vanderbilt University, Nashville, TN, United States.
David H ZaldPsychology, Vanderbilt University, Nashville, TN, United States; Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Daniel O ClaassenNeurology, Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: daniel.claassen@vanderbilt.edu.
Vanderbilt University Medical Center · USUniversity of Alabama at Birmingham · USVanderbilt University · US
Funding
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4MResearch Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1MBiological Determinants of Impulsivity in Parkinson's DiseaseR01NS097783 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CLAASSEN, DANIEL OLIVER · 2016 to 2020
$2.2MDopaminergic Modulation of Subjective Valuation across AdulthoodR01AG044838 · NIA · VANDERBILT UNIVERSITY · PI ZALD, DAVID HAROLD · 2012 to 2014
$1.6MDopamine Effects on Mesocorticolimbic Function in Parkinson DiseaseK23NS080988 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CLAASSEN, DANIEL OLIVER · 2013 to 2017
$904kRadiofluorination Equipment for PET Imaging ResearchS10OD019963 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MANNING, HENRY CHARLES · 2016 to 2016
$291kLinking Temporal Differences in d-Amphetamine Subjective Effects to DRD2 and DATF32DA041157 · NIDA · VANDERBILT UNIVERSITY · PI SMITH, CHRISTOPHER THOMAS · 2016 to 2018
$174kNICHD NIH HHS U54 HD083211NIDA NIH HHS F32 DA041157NIH HHS K23NS080988NIH HHS R01AG044838NIH HHS UL1TR000445NINDS NIH HHS R01 NS097783
Abstract
Parkinson's disease (PD) is characterized by widespread degeneration of monoaminergic (especially dopaminergic) networks, manifesting with a number of both motor and non-motor symptoms. Regional alterations to dopamine D
Indexed as
AgedAged, 80 and overBenzamidesBrain MappingCorpus StriatumDopamine D2 Receptor AntagonistsFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleParkinson DiseasePositron-Emission TomographyReceptors, Dopamine D2BenzamidesDopamine D2 Receptor AntagonistsfallyprideFluorodeoxyglucose F18Receptors, Dopamine D2BPND, Binding potential (nondisplaceable)CES-D, Center for Epidemiologic Studies Depression ScaleDopamineFallyprideHC, Healthy controlsLEDD, Levodopa Daily DoseMDS-UPDRS, Movement Disorders Society-United Parkinson's disease Rating ScaleMoCA, Montreal Cognitive AssessmentNeurodegenerationParkinson's diseasePD, Parkinson's diseasePET, Positron emission tomographyPositron emission tomography (PET)ROI, Region of Interest
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.